Development of a new methodology for dissolving tablets containing diltiazem hydrochloride marketed in Brazil using design of experiment
Authors:
- Laura Beatriz Souza e SouzaLSLaura Beatriz Souza e Souza
- Ivana Ferreira SimõesISIvana Ferreira Simões
- Orlando Maia BarbozaOBOrlando Maia Barboza
- Anderson Silva de OliveiraAOAnderson Silva de Oliveira
- Daniel Levi França da SilvaDSDaniel Levi França da Silva
- Walter Nei Lopes dos SantosWSWalter Nei Lopes dos Santos
- Aníbal de Freitas Santos JúniorAníbal de Freitas Santos Júnior
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 62
Abstract
Diltiazem hydrochloride (DH) is a calcium channel blocker used to modify or restore normal heart rhythm in cardiovascular diseases. The aim of this study was to develop and validate a new innovative method using UV molecular absorption spectrophotometry to evaluate the in vitro dissolution of DH using a factorial design of experiments. Physical and physicochemical tests were performed. The dissolution profiles of DH tablets (30 and 60 mg) available as the reference, generic and similar drugs were compared. The dissolution test was used to obtain and compare dissolution profiles and to determine the similarity of pharmaceutical formulations (USP type 2 apparatus at 75 rpm, with 750 mL of water at 37.0 ± 0.5 oC for 120 minutes). Only samples G30 and G60 showed compliance with the parameters established by the Brazilian Pharmacopoeia in all tests. Drug dissolution percentages are in accordance with the Brazilian and American Pharmacopoeias (>75% dissolution in 180 minutes). Using the proposed new method, it was observed that > 80% of DH was released in approximately 60 minutes. The proposed method was found to be sensitive, rapid and efficient for the quality control of DH tablets.Keywords
This publication has 16 references indexed in Scilit:
- Nutraceutical tablets: Manufacturing processes, quality assurance, and effects on human healthFood Research International, 2024
- Development and assessment of immediate-release tablets containing clopidogrel bisulphate & aspirin—strategy for optimizing the combination formulationPLOS ONE, 2024
- Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and PerspectivesBioMed Research International, 2021
- Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectivesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2020
- Analytical quality by design: Development and control strategy for a LC method to evaluate the cannabinoids content in cannabis olive oil extractsJournal of Pharmaceutical and Biomedical Analysis, 2019
- In Vitro Dissolution Profiles of Two Diltiazem Tablet Formulations and a Compounded Capsule Formulation: A Comparative StudyDissolution Technologies, 2017
- Dissolution Testing for Generic Drugs: An FDA PerspectiveThe AAPS Journal, 2011
- Development and validation of a dissolution test for diltiazem hydrochloride in immediate release capsulesQuímica Nova, 2011
- Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical ClassificationMolecular Pharmaceutics, 2003
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995